<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Saputra OA</submitter><funding>Universitas Sebelas Maret</funding><pagination>20661</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9712501</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>Controlling the premature release of hydrophobic drugs like quercetin over physiological conditions remains a challenge motivating the development of smart and responsive drug carriers in recent years. This present work reported a surface modification of mesoporous silica nanoparticles (MSN) by a functional compound having both amines (as a positively charged group) and carboxylic (negatively charged group), namely 4-((2-aminoethyl)amino)-4-oxobut-2-enoic acid (AmEA) prepared via simple mechanochemistry approach. The impact of MSN surface modification on physical, textural, and morphological features was evaluated by TGA, N&lt;sub>2&lt;/sub> adsorption-desorption, PSA-zeta, SEM, and TEM. The BET surface area of AmEA-modified MSN (MSN-AmEA) was found to be 858.41 m&lt;sup>2&lt;/sup> g&lt;sup>-1&lt;/sup> with a pore size of 2.69 nm which could accommodate a high concentration of quercetin 118% higher than MSN. In addition, the colloidal stability of MSN-AmEA was greatly improved as indicated by high zeta potential especially at pH 4 compared to MSN. In contrast to MSN, MSN-AmEA has better in controlling quercetin release triggered by pH, thanks to the presence of the functional groups that have a pose-sensitive interaction hence it may fully control the quercetin release, as elaborated by the DFT study. Therefore, the controlled release of quercetin over MSN-AmEA verified its capability of acting as a smart drug delivery system.</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Organically surface engineered mesoporous silica nanoparticles control the release of quercetin by pH stimuli.</pubmed_title><pmcid>PMC9712501</pmcid><funding_grant_id>514/UN27.21/HK/2020</funding_grant_id><pubmed_authors>Mukti RR</pubmed_authors><pubmed_authors>Lestari WW</pubmed_authors><pubmed_authors>Lestari WA</pubmed_authors><pubmed_authors>Martien R</pubmed_authors><pubmed_authors>Sugiura T</pubmed_authors><pubmed_authors>Wibowo FR</pubmed_authors><pubmed_authors>Saputra OA</pubmed_authors><pubmed_authors>Kurniansyah V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Organically surface engineered mesoporous silica nanoparticles control the release of quercetin by pH stimuli.</name><description>Controlling the premature release of hydrophobic drugs like quercetin over physiological conditions remains a challenge motivating the development of smart and responsive drug carriers in recent years. This present work reported a surface modification of mesoporous silica nanoparticles (MSN) by a functional compound having both amines (as a positively charged group) and carboxylic (negatively charged group), namely 4-((2-aminoethyl)amino)-4-oxobut-2-enoic acid (AmEA) prepared via simple mechanochemistry approach. The impact of MSN surface modification on physical, textural, and morphological features was evaluated by TGA, N&lt;sub>2&lt;/sub> adsorption-desorption, PSA-zeta, SEM, and TEM. The BET surface area of AmEA-modified MSN (MSN-AmEA) was found to be 858.41 m&lt;sup>2&lt;/sup> g&lt;sup>-1&lt;/sup> with a pore size of 2.69 nm which could accommodate a high concentration of quercetin 118% higher than MSN. In addition, the colloidal stability of MSN-AmEA was greatly improved as indicated by high zeta potential especially at pH 4 compared to MSN. In contrast to MSN, MSN-AmEA has better in controlling quercetin release triggered by pH, thanks to the presence of the functional groups that have a pose-sensitive interaction hence it may fully control the quercetin release, as elaborated by the DFT study. Therefore, the controlled release of quercetin over MSN-AmEA verified its capability of acting as a smart drug delivery system.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-26T12:33:34.823Z</modification><creation>2025-04-06T14:01:28.688Z</creation></dates><accession>S-EPMC9712501</accession><cross_references><pubmed>36450792</pubmed><doi>10.1038/s41598-022-25095-4</doi></cross_references></HashMap>